Open AccessSuccessful Treatment with Bromocriptine of Hypertension Associated with Polycystic Ovarian Disease
Author(s) -
Ito Masaharu,
Matsuura Kohei,
Aiko Akira,
Matsui Kazuo,
Yoshimura Toshihiro,
Okamura Hitoshi
Publication year - 1987
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016348709020764
Subject(s) - medicine , bromocriptine , polycystic ovarian disease , gynecology , polycystic ovary , endocrinology , prolactin , diabetes mellitus , insulin resistance , hormone
The use of bromocriptine, 5 mg per day, markedly improved the severe hypertension (up to 180/120 mmHg) of a patient suffering from polycystic ovarian disease (PCOD). The response was rapid, with decreasing concentrations of serum testosterone and 11‐deoxycorticosterone (DOC). Bromocriptine induced further renewal of the ovulatory cycle. Bromocriptine may thus be of considerable value in the treatment hypertensive patients with PCOD.